Seeing Is Believing
Currently out of the existing stock ratings of Anne Edelstein, 3 are a BUY (100%).
Analyst Anne Edelstein, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 100% that have a potential upside of 15.87% achieved within 62 days. Previously, Anne Edelstein worked at BAML.
Anne Edelstein’s has documented 7 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EXAS, EXACT Sciences at 29-Nov-2017.
Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 10/19/2017. The price target of $56 was fulfilled within 15 days with a profit of $8.47 (17.82%) receiving and performance score of 11.88.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$105
$3.71 (3.66%)
$75
19 days ago
(25-Nov-2025)
9/13 (69.23%)
$3.87 (3.83%)
406
Buy
$105
$3.71 (3.66%)
$85
20 days ago
(24-Nov-2025)
21/24 (87.5%)
$3.99 (3.95%)
203
Buy
$75
20 days ago
(24-Nov-2025)
14/14 (100%)
$8.02 (11.97%)
205
Buy
$105
$3.71 (3.66%)
$77
23 days ago
(21-Nov-2025)
8/9 (88.89%)
$4.1 (4.06%)
126
Buy
$80
$-21.29 (-21.02%)
$70
1 months 3 days ago
(11-Nov-2025)
13/13 (100%)
$12.5 (18.52%)
284
What Year was the first public recommendation made by Anne Edelstein?